Literature DB >> 14070379

EXPERIMENTAL AND CLINICAL USE OF FLUORINATED PYRIMIDINES IN CANCER CHEMOTHERAPY.

C HEIDELBERGER, F J ANSFIELD.   

Abstract

Entities:  

Keywords:  BREAST NEOPLASMS; CARBON ISOTOPES; FLUORODEOXYURIDINE; FLUOROURACIL; GASTROINTESTINAL NEOPLASMS; METABOLISM; NEOPLASM THERAPY; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; REVIEW

Mesh：

Substances：

Year:  1963        PMID： 14070379

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  31 in total

1.  A sensitive assay of 5-fluorouracil in plasma by gas chromatography-mass spectrometry.

Authors:  B L Hillcoat; M Kawai; P B McCulloch; J Rosenfeld; C K Williams
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 2.  Biologics in bowel cancer.

Authors:  Marcus S Noel
Journal:  J Gastrointest Oncol       Date:  2017-06

3.  The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro.

Authors:  R Kanamaru; H Kakuta; T Sato; C Ishioka; A Wakui
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 4.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 5.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

Review 6.  5-Fluorouracil radiation sensitization--a brief review.

Authors:  J E Byfield
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

7.  Reproducibility of tumor volume measurement at microCT colonography in living mice.

Authors:  Benjamin Y Durkee; Sarah R Mudd; Calista N Roen; Linda Clipson; Michael A Newton; Jamey P Weichert; Perry J Pickhardt; Richard B Halberg
Journal:  Acad Radiol       Date:  2008-03       Impact factor: 3.173

8.  Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivative.

Authors:  S Takeda; J Yamashita; H Saito; J Uchida; H Satake; Y Yamada; N Unemi; Y Wataya; H Hayatsu
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 9.  Update on cancer chemotherapy: general considerations and breast cancer. Part II.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-09       Impact factor: 1.798

10.  Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.

Authors:  J Balzarini; E De Clercq; D Ayusawa; T Seno
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.